PDRNEvidence library
PDRNEvidence library

Tools

INCI Translator

Learn

Topical vs InjectableHow PDRN WorksHomeWhat is PDRN

Evidence

Evidence libraryProduct databaseRetracted & correctedHow we grade studies

Site

About

Adenosine

G_ADENOSINE
MechanismBack to all terms

What does this word mean?

The key ligand produced when PDRN degrades, and the trigger that starts the entire signalling chain.

Expanded note

PDRN does not bind the receptor directly. The parent molecule is first enzymatically degraded into deoxyribonucleotide fragments, from which adenine-class species are further metabolised into adenosine, and adenosine is the true ligand for the A2A receptor. This is why degradation before activity is the essential premise of this ingredient.

A real example from our data

Not a generic example.

Step 1 of the site mechanism chain, enzymatic degradation into deoxyribonucleotide fragments, exists to make this step possible (PMID 40231205).

Related terms

Adenosine A2A receptorThe primary molecular target of PDRN, a G protein-coupled receptor that is engaged by adenosine and starts the downstream cascade.cAMP (cyclic adenosine monophosphate)A second messenger whose intracellular level rises after the A2A receptor is activated.

Where this term appears

How PDRN Works · step 2 →
high
PMID 40231205 (Oh 2025, Biomater Res); PMID 27791262 (Veronesi 2017)
PMID 40231205 (Oh 2025, Biomater Res); PMID 27791262 (Veronesi 2017)

Educational reference only. This site does not provide medical advice, treatment courses, injection counts, clinic recommendations or price recommendations.

PDRN is not approved by the FDA for injection or any therapeutic use. Topical and injectable PDRN are parallel facts under different regulatory pathways and must not be directly equated.

PN is not PDRN. Evidence grades are labelled on every factual element; in vitro and animal research is never described as clinical efficacy.